glp-1 roche obesity drug helps patients shed 22.7% of weight in mid-stage trial Spotted in @oprahdaily. ✨ @volulift

They are used to treat type-2 diabetes and/or obesity alongside a reduced calorie diet and regular exercise

But these kinds of claims belong firmly in the all hype zone

In any GLP-1 weight loss plan, structured and consistent oversight is important to ensure safety and appropriate dose adjustments over time

Most research on the peptide has been done in animals although some human studies have been carried out [2]

This convergence of rising demand, regulatory scrutiny, and manufacturing ambition is reshaping Indias pharmaceutical landscape, particularly in the high-growth segment of GLP-1 receptor agonists (GLP1-RAs)